71 related articles for article (PubMed ID: 22111776)
1. Advances in oral anticoagulants: focus on dabigatran etexilate.
Hazlewood KA; Weiland CM
Expert Rev Clin Pharmacol; 2010 Nov; 3(6):727-37. PubMed ID: 22111776
[TBL] [Abstract][Full Text] [Related]
2. Dabigatran etexilate: an oral direct thrombin inhibitor for prophylaxis and treatment of thromboembolic diseases.
Baetz BE; Spinler SA
Pharmacotherapy; 2008 Nov; 28(11):1354-73. PubMed ID: 18956996
[TBL] [Abstract][Full Text] [Related]
3. Dabigatran etexilate: the first oral anticoagulant available in the United States since warfarin.
Tran A; Cheng-Lai A
Cardiol Rev; 2011; 19(3):154-61. PubMed ID: 21464643
[TBL] [Abstract][Full Text] [Related]
4. Dabigatran: a new option for anticoagulation in atrial fibrillation and venous thromboembolism.
Acharjee S; Cannon CP
Crit Pathw Cardiol; 2011 Jun; 10(2):84-6. PubMed ID: 21988948
[TBL] [Abstract][Full Text] [Related]
5. [Clinical studies, the interests and limits of using dabigatran in atrial fibrillation].
Sternotte A; Douxfils J; Chatelain B; Chatelain C; Mullier F; Dogné JM; Spinewine A
J Pharm Belg; 2012 Mar; (1):8-17. PubMed ID: 22536678
[TBL] [Abstract][Full Text] [Related]
6. New oral anticoagulants in atrial fibrillation.
Turpie AG
Eur Heart J; 2008 Jan; 29(2):155-65. PubMed ID: 18096568
[TBL] [Abstract][Full Text] [Related]
7. The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism.
Mavrakanas T; Bounameaux H
Pharmacol Ther; 2011 Apr; 130(1):46-58. PubMed ID: 21185864
[TBL] [Abstract][Full Text] [Related]
8. Role of emerging antithrombotic therapy in the prevention of cardioembolic complications in patients with atrial fibrillation.
Deedwania PC; Huang GW
Am J Cardiovasc Drugs; 2011 Aug; 11(4):265-75. PubMed ID: 21740079
[TBL] [Abstract][Full Text] [Related]
9. Advances in anticoagulation: focus on dabigatran, an oral direct thrombin inhibitor.
Augoustides JG
J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):1208-12. PubMed ID: 21982327
[TBL] [Abstract][Full Text] [Related]
10. Oral anticoagulation with factor Xa and thrombin inhibitors: on the threshold of change.
Zikria JC; Ansell J
Curr Opin Hematol; 2009 Sep; 16(5):347-56. PubMed ID: 19550318
[TBL] [Abstract][Full Text] [Related]
11. A review of the oral direct thrombin inhibitor ximelagatran: not yet the end of the warfarin era..
Mohapatra R; Tran M; Gore JM; Spencer FA
Am Heart J; 2005 Jul; 150(1):19-26. PubMed ID: 16084146
[TBL] [Abstract][Full Text] [Related]
12. [Dabigatran, a new oral anticoagulant].
Uchiyama S
Brain Nerve; 2011 Apr; 63(4):411-5. PubMed ID: 21441645
[TBL] [Abstract][Full Text] [Related]
13. Preventing stroke in atrial fibrillation: the SPORTIF programme.
Lip GY
Pathophysiol Haemost Thromb; 2005; 34 Suppl 1():25-30. PubMed ID: 15812201
[TBL] [Abstract][Full Text] [Related]
14. Dabigatran etexilate: advances in anticoagulation therapy.
Dahl OE; Huisman MV
Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):771-4. PubMed ID: 20528634
[TBL] [Abstract][Full Text] [Related]
15. Dabigatran for the prevention of thromboembolic complications in the elderly: a RE-LY-able alternative to warfarin?
Hughes PJ; Freeman MK
Consult Pharm; 2012 Jun; 27(6):445-52. PubMed ID: 22698551
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic treatment failures in antiphospholipid syndrome: the new anticoagulants?
Cohen H; Machin SJ
Lupus; 2010 Apr; 19(4):486-91. PubMed ID: 20353992
[TBL] [Abstract][Full Text] [Related]
17. Direct thrombin inhibitors for the treatment of venous thromboembolism: analysis of the Dabigatran versus Warfarin clinical trial.
Liem TK; Deloughery TG
Semin Vasc Surg; 2011 Sep; 24(3):157-61. PubMed ID: 22153026
[TBL] [Abstract][Full Text] [Related]
18. Novel anticoagulants in clinical development: focus on factor Xa and direct thrombin inhibitors.
Steffel J; Lüscher TF
J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):616-23. PubMed ID: 19561526
[TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation and dabigatran: has the time come to use new anticoagulants?
Escobar C; Barrios V; Jimenez D
Cardiovasc Ther; 2010 Oct; 28(5):295-301. PubMed ID: 20718760
[TBL] [Abstract][Full Text] [Related]
20. The role of ximelagatran in the treatment of venous thromboembolism.
Schulman S
Pathophysiol Haemost Thromb; 2005; 34 Suppl 1():18-24. PubMed ID: 15812200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
